Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-025 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F5-05 |
filingDate |
2013-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2017-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2017-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-104203961-B |
titleOfInvention |
Boron-based 4-hydroxytamoxifen and endoxifen prodrugs for treating breast cancer |
abstract |
The present disclosure relates to various boron-based 4-hydroxytamoxifen and endoxifen prodrugs and the synthesis of the same. Further, the present disclosure teaches the utilization of the boron- based 4-hydroxytamoxifen and endoxifen prodrugs in a treatment for breast cancer. |
priorityDate |
2012-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |